Suppr超能文献

蛋白酶体:炎症和巨噬细胞功能的核心调节因子。

The proteasome: a central regulator of inflammation and macrophage function.

作者信息

Qureshi Nilofer, Vogel Stefanie N, Van Way Charles, Papasian Christopher J, Qureshi Asaf A, Morrison David C

机构信息

Department of Basic Medical Science, School of Medicine, Shock/Trauma Research Center, University of Maryland-Baltimore, Baltimore, MD, USA.

出版信息

Immunol Res. 2005;31(3):243-60. doi: 10.1385/IR:31:3:243.

Abstract

Proteasomes, multisubunit complexes that consist of a 20S proteasome and a 19S regulatory complex, are essential for several cellular processes. Our interest in the proteasome complex stems from our observations that a novel photoactivable lipopolysaccharide (LPS) probe binds to specific proteasome subunits, and that LPS enhances the chymotrypsin-like activity of the proteasome to degrade synthetic peptides in vitro. Experiments with proteasome inhibitors have shown that expression of many LPS-inducible genes, including TLR2, is inhibited in macrophages. More important, proteasome inhibitors such as lactacystin can prevent LPS-induced shock in mice. This article focuses on the role of the proteasome in the development of inflammatory processes, which may result in septic shock, hemorrhagic shock, atherosclerosis, and neurodegenerative disorders. Taken collectively, the results suggest a potentially important role of the proteasome in inflammation and other macrophage functions.

摘要

蛋白酶体是由一个20S蛋白酶体和一个19S调节复合体组成的多亚基复合体,对多种细胞过程至关重要。我们对蛋白酶体复合体的兴趣源于我们的观察结果,即一种新型的可光活化脂多糖(LPS)探针可与特定的蛋白酶体亚基结合,并且LPS可增强蛋白酶体的类胰凝乳蛋白酶活性,以在体外降解合成肽。蛋白酶体抑制剂实验表明,包括TLR2在内的许多LPS诱导基因的表达在巨噬细胞中受到抑制。更重要的是,诸如乳胞素之类的蛋白酶体抑制剂可预防小鼠的LPS诱导的休克。本文重点关注蛋白酶体在炎症过程发展中的作用,炎症过程可能导致败血症性休克、出血性休克、动脉粥样硬化和神经退行性疾病。总体而言,这些结果表明蛋白酶体在炎症和其他巨噬细胞功能中可能具有重要作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验